-
Something wrong with this record ?
Modified creatine greatly increases the performance of skeletal and smooth muscles
A. Soloviev, V. Kozlovsky, D. Nozdrenko, V. Sydorenko, I. Monchak, N. Vdovenko, O. Maidaniuk, V. Fetyukhin
Status not-indexed Language English Country Netherlands
Document type Journal Article
NLK
Directory of Open Access Journals
from 2015
PubMed Central
from 2015
Open Access Digital Library
from 2015-05-01
ROAD: Directory of Open Access Scholarly Resources
from 2015
- Publication type
- Journal Article MeSH
Creatine is a nitrogen-containing carboxylic acid and a main component of phosphocreatine. In recent years, creatine is considered as a component of dietary nutrition, to improve the efficiency of physical activity and increase muscle mass of athletes and older people. Creatine has been shown to be able restore cardiac contractility impairment after myocardial infarction. However, as muscle cells do not synthesise creatine, the efficiency of creatine depends on its transmembrane transport. In our study, we evaluated the effect of «ProCreatine» (ProCr), a novel membrane transporter-independent creatine modification on fatigability of the rat gastrocnemius muscle and portal vein smooth muscle using fatigue stimulation pools. Mechanokinetic and biomechanical markers of fatigue in muscles to maintain the level of isometric tension induced by field electrical stimulation were examined. The results indicate that administration of ProCr to skeletal muscle significantly increases maximal force output, integrated muscle contractile force and significantly increases muscle productivity. We observed positive changes in all studied biochemical indices of fatigue. In addition, ProCr increases the duration of sustaining a constant level of isometric contraction in portal vein smooth muscle caused by electrical stimulation by 6 fold. Regular creatine in the same dose had no significant effect on these parameters neither in skeletal nor in smooth muscles. The data obtained suggest the possibility of using ProCr as a therapeutic agent capable of reducing and correcting pathological conditions of the muscular system that arise during the processes of fatigue in skeletal muscles and smooth muscles of hollow organs.
1 F Lab LLC Life Chemicals Inc Distributor Kyiv 02094 Ukraine
ESC Institute of Biology and Medicine Taras Shevchenko National University of Kyiv 03127 Ukraine
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25008318
- 003
- CZ-PrNML
- 005
- 20250422095750.0
- 007
- ta
- 008
- 250408e20250128ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbrep.2025.101934 $2 doi
- 035 __
- $a (PubMed)39944466
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Soloviev, Anatoly $u Department for Pharmacology of Cellular Signal Systems and Experimental Therapeutics, Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, 03057, Ukraine
- 245 10
- $a Modified creatine greatly increases the performance of skeletal and smooth muscles / $c A. Soloviev, V. Kozlovsky, D. Nozdrenko, V. Sydorenko, I. Monchak, N. Vdovenko, O. Maidaniuk, V. Fetyukhin
- 520 9_
- $a Creatine is a nitrogen-containing carboxylic acid and a main component of phosphocreatine. In recent years, creatine is considered as a component of dietary nutrition, to improve the efficiency of physical activity and increase muscle mass of athletes and older people. Creatine has been shown to be able restore cardiac contractility impairment after myocardial infarction. However, as muscle cells do not synthesise creatine, the efficiency of creatine depends on its transmembrane transport. In our study, we evaluated the effect of «ProCreatine» (ProCr), a novel membrane transporter-independent creatine modification on fatigability of the rat gastrocnemius muscle and portal vein smooth muscle using fatigue stimulation pools. Mechanokinetic and biomechanical markers of fatigue in muscles to maintain the level of isometric tension induced by field electrical stimulation were examined. The results indicate that administration of ProCr to skeletal muscle significantly increases maximal force output, integrated muscle contractile force and significantly increases muscle productivity. We observed positive changes in all studied biochemical indices of fatigue. In addition, ProCr increases the duration of sustaining a constant level of isometric contraction in portal vein smooth muscle caused by electrical stimulation by 6 fold. Regular creatine in the same dose had no significant effect on these parameters neither in skeletal nor in smooth muscles. The data obtained suggest the possibility of using ProCr as a therapeutic agent capable of reducing and correcting pathological conditions of the muscular system that arise during the processes of fatigue in skeletal muscles and smooth muscles of hollow organs.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kozlovsky, Vadym $u LLC "MEDIVALEX", Prague, 15200, Czech Republic
- 700 1_
- $a Nozdrenko, Dmytro $u ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 03127, Ukraine
- 700 1_
- $a Sydorenko, Vadym $u Department for Pharmacology of Cellular Signal Systems and Experimental Therapeutics, Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, 03057, Ukraine
- 700 1_
- $a Monchak, Igor $u Department for Pharmacology of Cellular Signal Systems and Experimental Therapeutics, Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, 03057, Ukraine
- 700 1_
- $a Vdovenko, Natalia $u Department of Medical and Biological Disciplines, State Scientific Research Institute of Physical Culture and Sports, 03131, Kyiv, Ukraine
- 700 1_
- $a Maidaniuk, Olena $u Department of Medical and Biological Disciplines, State Scientific Research Institute of Physical Culture and Sports, 03131, Kyiv, Ukraine
- 700 1_
- $a Fetyukhin, Volodymyr $u I.F. Lab, LLC, Life Chemicals Inc. Distributor, Kyiv, 02094, Ukraine
- 773 0_
- $w MED00205982 $t Biochemistry and biophysics reports $x 2405-5808 $g Roč. 41 (20250128), s. 101934
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39944466 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250408 $b ABA008
- 991 __
- $a 20250422095751 $b ABA008
- 999 __
- $a ok $b bmc $g 2306335 $s 1245393
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 41 $c - $d 101934 $e 20250128 $i 2405-5808 $m Biochemistry and biophysics reports $n Biochem Biophys Rep $x MED00205982
- LZP __
- $a Pubmed-20250408